SAN

74.115

-4.79%↓

SRT3

223.85

+3.01%↑

ORNBV.FI

68.5

+3.4%↑

SAN

74.115

-4.79%↓

SRT3

223.85

+3.01%↑

ORNBV.FI

68.5

+3.4%↑

SAN

74.115

-4.79%↓

SRT3

223.85

+3.01%↑

ORNBV.FI

68.5

+3.4%↑

SAN

74.115

-4.79%↓

SRT3

223.85

+3.01%↑

ORNBV.FI

68.5

+3.4%↑

SAN

74.115

-4.79%↓

SRT3

223.85

+3.01%↑

ORNBV.FI

68.5

+3.4%↑

Home・Stock List・Carl Zeiss Meditec AG

Search

Carl Zeiss Meditec AG

Closed

SectorHealthcare

26.46 5.42

Overview

Share price change

24h

Current

Min

26.28

Max

26.48

Key metrics
By Trading Economics
Income	52M 80M
Sales	-161M 467M
P/E Sector Avg	16.422 67.147
EPS	0.03
Dividend yield	2.09
Profit margin	12.778
Employees	5,784
EBITDA	124M 187M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+8.04% upside

Dividends
By Dow Jones
Dividend yield Sector Avg	2.09% 2.36%
Next Earnings	12 May 2026

Market Stats
By TradingEconomics
Market Cap	-1.2B 2.3B
Previous open	21.04
Previous close	26.46

News Sentiment

By Acuity

27%

73%

85 / 347 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

58.75 / 60.35 Support & Resistance

Carl Zeiss Meditec AG Chart

Past performance is not a reliable indicator of future results.

Related News

4 May 2026, 22:17 UTC

Earnings

Australia's Westpac Lifts Dividend as 1st Half Profit Rises 2.7%

4 May 2026, 23:47 UTC

Earnings

Grab Holdings 1Q Adj EBITDA $154.0M Vs. $106.0M >GRAB

4 May 2026, 23:45 UTC

Earnings

Grab Holdings 1Q Rev $955.0M Vs. $773.0M >GRAB

4 May 2026, 23:45 UTC

Earnings

Grab Holdings 1Q Net $120.0M Vs. Net $10.0M >GRAB

4 May 2026, 23:40 UTC

Market Talk

Gold Steady Amid Likely Technical Recovery -- Market Talk

4 May 2026, 22:44 UTC

Acquisitions, Mergers, Takeovers

Regis: Jim Beyer To Be Chief Executive of Combined Company

4 May 2026, 22:43 UTC

Acquisitions, Mergers, Takeovers

Regis: Russell Clark To Be Nonexecutive Chairman of Combined Company

4 May 2026, 22:42 UTC

Acquisitions, Mergers, Takeovers

Regis: Companies Expect to Realize Over A$500 Million in Corporate Tax Benefits

4 May 2026, 22:42 UTC

Acquisitions, Mergers, Takeovers

Regis: Combined Company to Have Strong, Debt-Free Balance Sheet; Significant Cash Generation

4 May 2026, 22:41 UTC

Acquisitions, Mergers, Takeovers

Regis: Combined Company to Have Annual Production of More Than 700,000 Oz

4 May 2026, 22:41 UTC

Acquisitions, Mergers, Takeovers

Regis: Pro Forma Market Capitalization About A$10.7 Billion

4 May 2026, 22:40 UTC

Acquisitions, Mergers, Takeovers

Regis: Shareholders to Own About 51% of Combined Company

4 May 2026, 22:40 UTC

Acquisitions, Mergers, Takeovers

Regis: Board Unanimously Endorsed, Supported Deal

4 May 2026, 22:40 UTC

Acquisitions, Mergers, Takeovers

Regis: Deal Unanimously Recommended by Vault Board

4 May 2026, 22:39 UTC

Acquisitions, Mergers, Takeovers

Regis: Vault Shareholders to Receive 0.6947 New Shares in Regis For Each Vault One Held

4 May 2026, 22:38 UTC

Acquisitions, Mergers, Takeovers

Regis Resources to Acquire All Ordinary Shares in Vault

4 May 2026, 22:38 UTC

Acquisitions, Mergers, Takeovers

Regis Resources, Vault Minerals Agree to Merger of Equals

4 May 2026, 22:37 UTC

Earnings

Acquisitions, Mergers, Takeovers

Palantir Beats Forecasts With $1.63 Billion Quarter as Sales Accelerate -- 2nd Update

4 May 2026, 22:26 UTC

Earnings

Acquisitions, Mergers, Takeovers

Palantir Beats Forecasts With $1.63 Billion Quarter as Sales Accelerate -- Update

4 May 2026, 22:02 UTC

Earnings

Australia's Westpac Lifts Dividend as 1H Profit Rises 2.7%

4 May 2026, 22:00 UTC

Market Talk

BOC's Macklem: Conditions To Dictate Fuel-Price Response -- Market Talk

4 May 2026, 21:52 UTC

Earnings

Westpac 1H Net Profit Ex-Notable Items A$3.48B Vs. A$3.46B>WBC.AU

4 May 2026, 21:50 UTC

Earnings

Westpac: Some Sectors More Affected Than Others>WBC.AU

4 May 2026, 21:50 UTC

Earnings

Westpac: Economic Impact of Middle East Conflict to Continue Through Year>WBC.AU

4 May 2026, 21:49 UTC

Earnings

Westpac 1H Provision for Expected Credit Losses A$4.68B Vs. A$4.58B>WBC.AU

4 May 2026, 21:44 UTC

Earnings

Westpac 1H Australia Lending Up 8% on Year>WBC.AU

4 May 2026, 21:44 UTC

Earnings

Westpac 1H Australia Business Lending Up 16% on Year>WBC.AU

4 May 2026, 21:43 UTC

Earnings

Westpac 1H Core Net Interest Margin 1.78% Vs. 1.80%>WBC.AU

4 May 2026, 21:41 UTC

Earnings

Westpac 1H Australian Home Lending Up 7% on Year Excluding RAMS Portfolio>WBC.AU

4 May 2026, 21:40 UTC

Earnings

Westpac 1H Credit Impairment Charge 10 Bps of Average Loans Vs. 6 Bps>WBC.AU

Peer Comparison

Price change

Carl Zeiss Meditec AG Forecast

Price Target

By TipRanks

8.04% upside

12 Months Forecast

Average 28.61 EUR 8.04%

High 32 EUR

Low 22.4 EUR

Based on 9 Wall Street analysts offering 12 month price targets forCarl Zeiss Meditec AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

9 ratings

0

Buy

8

Hold

1

Sell

Based on 9 analysts giving stock ratings to Carl Zeiss Meditec AG - Dist in the past 3 months.

Technical Score

By Trading Central

58.75 / 60.35Support & Resistance

Recent bullish events outweigh bearish events.

All events are bullish.

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

85 / 347 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Other stocks from the sector

SAN

Sanofi SA

74.115

SRT3

Sartorius AG

223.85

ORNBV.FI

Orion Oyj (Class B)

68.5

Live chat